Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on: January 23,2024 15

Experimental monoclonal antibodies can coax aggressive prostate and breast cancers into submission, finds research

by Delthia Ricks , Medical XpressTherapeutic inhibition of VEGF binding to NRP2 activates anti-tumor immunity in a syngeneic model of prostate cancer that is resistant to aPD-L1 therapy. (A) Shown is

Updated on:January 23,2024 15

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on: January 12,2024 8

New research reviews myeloid-derived suppressor cells in cancer, autoimmune diseases, and more

by Impact Journals LLCMDSCs generated by obesity migrate to lymphoid organ and TME. Credit: 2022 Shibata et al.A new review titled "Myeloid-derived suppressor cells: Cancer, autoimmune diseases,

Updated on:January 12,2024 8

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on: January 13,2024 10

New study suggests way to predict outcomes with high accuracy prior to surgery for pancreatic cancer patients

by National Comprehensive Cancer NetworkPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteNew research in the September 2022 issue of&nbsp

Updated on:January 13,2024 10

Drug designed to treat metastatic pancreatic cancer may help extend life

by Stony Brook UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA drug developed by researchers at the Renaissance School of Me

Updated on: May 09,2024 7

Drug designed to treat metastatic pancreatic cancer may help extend life

by Stony Brook UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA drug developed by researchers at the Renaissance School of Me

Updated on:May 09,2024 7

Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on: November 11,2024 0

Low-cost, portable device can detect colorectal and prostate cancer in an hour

byUniversity of Texas at El PasoA team of researchers from The University of Texas at El Paso, led by Xiujun (James) Li, Ph.D., has created a low-cost, portable device that can detect colorectal

Updated on:November 11,2024 0

Research team develops new system for imaging and treating tumors

by Helmholtz Association of German Research CentresA suitable combination of radioactive elements in so-called radionuclide theranostics allows the visualization and treatment of cancer to be com

Updated on: February 18,2024 11

Research team develops new system for imaging and treating tumors

by Helmholtz Association of German Research CentresA suitable combination of radioactive elements in so-called radionuclide theranostics allows the visualization and treatment of cancer to be com

Updated on:February 18,2024 11

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

byUniversity of CambridgeCredit: Pixabay/CC0 Public DomainCambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The

Updated on: January 22,2024 17

Technique for tracking resistant cancer cells could lead to new treatments for relapsing breast cancer patients

byUniversity of CambridgeCredit: Pixabay/CC0 Public DomainCambridge scientists have managed to identify and kill those breast cancer cells that evade standard treatments in a study in mice. The

Updated on:January 22,2024 17

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on: March 05,2024 11

AI in personalized cancer medicine: New therapies require flexible and safe approval conditions

by Viktoria Bosak,Dresden University of TechnologyA perspective on the US and EU regulatory system readiness for AI-enabled personalized drug and cell-based therapies in precision oncology. The

Updated on:March 05,2024 11

Combination of photonic sensors and microfluidics could detect cancer markers within 20 minutes

by Andrei Korshunov,Skolkovo Institute of Science and TechnologyStudy co-author and Skoltech PhD student Aleksei Kuzin posing next to a measurement stand. He is holding thephotonic chip th

Updated on: March 05,2024 19

Combination of photonic sensors and microfluidics could detect cancer markers within 20 minutes

by Andrei Korshunov,Skolkovo Institute of Science and TechnologyStudy co-author and Skoltech PhD student Aleksei Kuzin posing next to a measurement stand. He is holding thephotonic chip th

Updated on:March 05,2024 19

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on: August 27,2024 0

Study shows Meteorin-like protein drains energy from T cells, limiting immune system's power to fight cancer

byJohns Hopkins University School of MedicineThe image on the right shows an unhealthy mitochondrion in a T cell exposed to METRNL. Credit: Christopher Jackson, M.D.A protein called Meteorin-lik

Updated on:August 27,2024 0

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on: February 23,2024 15

A new therapeutic strategy to improve treatment of aggressive endometrial cancer

by Autonomous University of BarcelonaERK5 inhibition impairs EC cell proliferation.AGenomic profiles of components of the MEK5-ERK5 pathway in EC patients obtained from Uterine Corpus

Updated on:February 23,2024 15

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc

Updated on: February 23,2024 20

Discovery could lead to new drugs to block protein that fuels bowel cancer

by Institute of Cancer ResearchUsing cryo-electron microscopy, researchers obtained a detailed map (shown in orange) of the chain-like tankyrase structure. By interpreting this map and reconstruc

Updated on:February 23,2024 20